Skip to content

Dysfunctional Hemoglobin Pulse Oximetry

Dysfunctional Hemoglobin Pulse Oximeter

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03030833
Enrollment
36
Registered
2017-01-25
Start date
2017-02-06
Completion date
2017-04-30
Last updated
2017-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carbon Monoxide Poisoning

Brief summary

The purpose of the study is to assess device performance in the presence of carbon monoxide.

Interventions

DEVICEPulse Oximeter

Comparison of pulse oximetry to blood gas analyzer.

Sponsors

Nonin Medical, Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years

Inclusion criteria

* The subject is male or female. * The subject is of any racial or ethnic group. * The subject is between 18 years and 50 years of age (self-reported). * The subject does not have significant medical problems (self-reported). * The subject is willing to provide written informed consent and is willing and able to comply with study procedures. *

Exclusion criteria

* Has a BMI greater than 30.0 (calculated from self-reported weight and height). * Has had any relevant injury at the sensor location site (self-reported). * Has a deformity or abnormalities that may prevent proper application of the device under test (based on visual inspection). * Has a known respiratory condition (self-reported). * Is currently a smoker (self-reported). * Has a known heart or cardiovascular condition (self-reported). * Is currently pregnant (positive serum pregnancy test at screening visit or positive urine POC test on day of study). * Is female and actively trying to get pregnant (self-reported). * Has a clotting disorder (self-reported). * Has Raynaud's Disease (self-reported). * Is known to have anemia (hemoglobin value below lower range of normal for gender) * Is known to have a hemoglobinopathy such as sickle-cell anemia or thalassemia (abnormal hemoglobin electrophoresis). * Is known to have a inherited or congenital methemoglobinemia (self-reported). * Has unacceptable collateral circulation from the ulnar artery (based on exam). * Is unwilling or unable to provide written informed consent to participate in the study. * Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.

Design outcomes

Primary

MeasureTime frameDescription
Carboxyhemoglobin accuracyThrough study completion, an average of 3 months.Values from the test device will be compared to the values from co-oximetry to determine accuracy of the test device.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026